In Latin America, the average percentage of the public budget for health is 12.75%, half of what is allocated by the 38 ...

US cardiorenal-focussed drugmaker Ardelyx (Nasdaq: ARDX) announced that Mike Kelliher, formerly executive vice president, ...

Sweden’s Sobi and US biopharma Apellis Pharmaceuticals have presented new data from the open-label period of the Phase III ...

The dynamics of the Friedreich's ataxia market are anticipated to change as companies across the globe work towards the ...

Texas-based ImmunoPrecise Antibodies (Nasdaq :IPA) a leader in AI-driven biotherapeutics, closed 22% higher Thursday. The ...

China-based Kelun-Biotech Biopharmaceutical (6990: HK) announced the placement of 5,918,000 H shares under its general ...

Japan’s Otsuka (TYO: 4578) today presented positive results from a pre-specified interim analysis of the Phase III VISIONARY study (NCT05248646) evaluating sibeprenlimab, for the treatment of ...